MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2024 International Congress

    Sex differences of gait at self-determined speed in neurodegenerative parkinsonism

    F. Jagusch, V. Sidoroff, G. Prigent, H. Moradi, S. Sapienza, JP. Ndayisaba, F. Krismer, H. Humer, P. Bachmann, K. Seppi, I. Teckenburg, M. Asalian, D. Benninger, BM. Eskofier, J. Winkler, J. Klucken, H. Gassner, A. Ionescu, K. Aminian, C. Raccagni, GK. Wenning (Innsbruck, Austria)

    Objective: To identify sex-specific differences in observer-independent gait parameters in parkinsonian disorders. Background: Reduced mobility and gait impairment impact the quality of life and increase…
  • 2024 International Congress

    Leveraging Large-Scale Proteomics to Identify Protein Quantitative Trait Loci and Causal Effects on Parkinson’s Disease

    M. Lai, B. Benitez (Boston, USA)

    Objective: Integrate proteomics from the cerebrospinal fluid (CSF) and urine from the Parkinson’s Progression Markers Initiative cohort to prioritize the risk variants associated with Parkinson’s…
  • 2024 International Congress

    Spastic Ataxia and Motorneuron disease as possible manifestations of ATP13A2 (PARK 9) variants

    G. Dalla Zanna, A. Funcis, S. Rossi, F. Santorelli, M. Sabatelli, G. Silvestri (Rome, Italy)

    Objective: To describe 5 late-onset sporadic cases carrying either biallelic or monoallelic variants in ATP13A2, showing either spastic ataxia(Spatax) or primary lateral sclerosis (PLS) as…
  • 2024 International Congress

    Understanding Patient and Care Partner Educational Preferences in Atypical Parkinsonism

    M. Ivancic, M. Comeau, R. Mahabir, C. Malburg, J. Shurer, K. Woods, E. Zivin, CY. Lin (Chapel Hill, USA)

    Objective: To discern preferences for education and community connection among people affected by progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), or multiple system atrophy (MSA).…
  • 2024 International Congress

    Peripheral immune profile and neutrophil-to-lymphocyte ratio in Progressive Supranuclear Palsy

    L. Muñoz-Delgado, A. Luque-Ambrosiani, B. Benítez Zamora, D. Macías-García, S. Jesús, AD. Adarmes‐gómez, E. Ojeda-Lepe, F. Carrillo, P. Mir (Sevilla, Spain)

    Objective: This study aimed to evaluate the peripheral immune profile in patients with Progressive Supranuclear Palsy (PSP) compared with patients with Parkinson’s disease (PD) and…
  • 2024 International Congress

    Clinical Utility of Synuclein Skin Biopsy in the Initial Diagnosis and Evaluation of Parkinsonian Disorders

    J. Isaacson, R. Freeman, C. Gibbons, A. Alshehri (Boston, USA)

    Objective: To determine the clinical utility of phosphorylated alpha-synuclein (P-SYN) within skin biopsies in diagnostic and management decisions. Background: The initial diagnosis of Parkinson’s Disease…
  • 2024 International Congress

    The impact of stimulation setting on Battery Longevity in Deep Brain Stimulation

    F. Yazdanian, A. Enriquez-Marulanda, N. Dehmamy, J. Shils, R. Alterman (boston, USA)

    Objective: This study aims to assess the estimated battery longevity and its determinants in Percept model of Deep Brain Stimulation (DBS) devices in patients diagnosed…
  • 2024 International Congress

    Unique Presentation of SPG 15 as Juvenile Levodopa Responsive Parkinsonism: A Case Report

    D. Nayar, A. Boddu, T. Virmani (little rock, USA)

    Objective: To present an atypical case of Hereditary Spastic Paraplegia (HSP) subtype SPG 15 manifesting as juvenile levodopa-responsive parkinsonism and the subsequent management decision for…
  • 2024 International Congress

    Systematic Review of Incidence and Prevalence Studies of Multiple System Atrophy

    B. Benzahia, E. Carter, D. Swallow (Aberdeen, United Kingdom)

    Objective: This study sought to systematically review the methods and results of previous incidence and prevalence studies of MSA. Background: High-quality incidence and prevalence studies…
  • 2024 International Congress

    Clinic vs Self-Referral for a Home-Based Fracture Prevention Trial of Zoledronate vs Placebo in Patients with Neurodegenerative Parkinsonism

    C. Tanner, N. Luthra, S. Goldman, R. Zuzuarregui, E. Brown, C. Meng, J. Perkins, T. Hue, C. Schambach, D. Kreisel, D. Young, I. Bledsoe, L. Racelo, P. Nanda Kumar, P. Ranola, M. Schwarzschild, R. Dorsey, A. Espay, S. Krischer, J. Falcon, C. Comella, M. Siddiqui, F. Gao, M. Ledoux, E. Byrd, I. Litvan, N. Mcfarland, K. Mitchell, D. Standaert, J. Beck, K. Williams, M. Drake, D. Bauer, K. Lyles, S. Cummings (SAN FRANCISCO, USA)

    Objective: To evaluate recruitment, eligibility and characteristics of clinic referred vs self-referred patients in the ongoing Trial of Parkinson’s and Zoledronate (TOPAZ, NCT03924414) Background: People…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley